- Issuer ticker
-
PLRX
- Reported as of
-
23 Jan 2023
- Net transaction value
-
-$2,327,630
- SEC form
-
4
- Accepted by SEC
-
25 Jan 2023, 20:00:38 UTC
Filing notes and source
Key filing fact
Eric Lefebvre filed Form 4 for PLIANT THERAPEUTICS, INC. (PLRX) on 25 Jan 2023.
Key facts
- This page summarizes Eric Lefebvre's Form 4 filing for PLIANT THERAPEUTICS, INC. (PLRX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 25 Jan 2023, 20:00.
Change
- Previous filing in this sequence was filed on 21 Dec 2022.
- Current net transaction value: -$2,327,630.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PLRX
transaction
Common Stock
Sale
- Transaction value
- -$2,327,630
- Shares
- -67,500
- Change %
- -47%
- Price
-
$34.48
- Shares after
- 76,926
- Date
- 23 Jan 2023
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote